-
New paper on nonregistration, discontinuation and nonpublication of randomized trials
May 5, 2022
National Pain Centre's Jason Busse co-author on new paper looking at the number of trials that don't make it to publication.
-
2022 Persistent Post-Surgical Pain Symposium Returns Triumphantly
May 3, 2022
The 2022 Persistent Post-Surgical Pain Symposium made its return after a two-year hiatus due to COVID-19.
-
Pain Canada launches, uniting organizations and advocates across the country
May 2, 2022
The new Pain Canada goes live, marking the official launch of the national action network.
-
Funding Opportunities Announced from Chronic Pain Centre of Excellence
April 25, 2022
Three Capacity Building Initiatives (CBIs) announced from the Chronic Pain Centre of Excellence for Canadian Veterans.
-
New study published on Declared Rationale for Cannabis Use Before and After Legalization for Nonmedical Use
April 20, 2022
New study finds legalization of recreational cannabis associated with substantial proportion change amongst Canadian adults who initially reported using cannabis for medical purposes.
-
Dr. Norm Buckley joins MeduCurrent to discuss Morphine and Opioids
February 15, 2022
Scientific Director of the Michael G. DeGroote Institute for Pain Research and Care, Dr Norm Buckley, appears on MeduCurrent episode 5 to break down and discuss opioids.
-
Evaluating Canadian Opioid Guideline discussed in UK's Research Features magazine
October 21, 2021
Dr. Norm Buckley presented the process of evaluating the Canadian Opioid Guideline (2017) in the UK's Research Features magazine.
-
New Rapid Recommendations released for Medical Cannabis or Cannabinoids for chronic pain.
September 24, 2021
MGD National Pain Centre director, Dr. Jason Busse's new Rapid Recommendations for Medical Cannabis for chronic pain now published in the British Medical Journal.
No items to display
/general-use/logos/external-group-logos/news-aoda.jpg?sfvrsn=f93f9048_2)